U.S. Software Stock News

Day One Biopharmaceuticals (DAWN) just reported its FY 2025 numbers, with Q4 total revenue of US$53.7 million and a net loss of US$21.3 million, setting the tone for how investors will read the year as a whole. The company has seen quarterly revenue move from US$29.2 million in Q4 2024 to US$53.7 million in Q4 2025, while Basic EPS shifted from a loss of US$0.64 per share in Q4 2024 to a loss of US$0.19 per share in Q3 2025, giving investors a clear view of how top line scale and loss levels...

Setting the scene on ACV Auctions ACV Auctions (ACVA) has drawn investor attention after a prolonged share price slump, with the stock showing negative returns over the past month, past 3 months, and year to date. At a last close of US$4.51, the wholesale digital auction platform sits against a backdrop of reported annual revenue of US$759.6 million and a net loss of US$66.1 million. This raises questions about how the business fundamentals compare with recent market sentiment. See our latest...

Universal Insurance Holdings FY 2025 Earnings Snapshot Universal Insurance Holdings (UVE) has wrapped up FY 2025 with fourth quarter total revenue of US$407.9 million and basic EPS of US$2.40, alongside net income of US$66.6 million as investors weigh these results against a year where net profit margin moved from 3.9% to 11.4% and earnings growth was very large at about 210.5% year over year. Over recent periods the company has seen total revenue shift from US$384.8 million and basic EPS of...

Laureate Education (NasdaqGS:LAUR) expanded its share repurchase authorization by $250 million, bringing the total program size to $400 million. The company has already completed a major tranche of this enlarged buyback, reducing its outstanding equity float. The move reflects management’s view of Laureate Education’s business outlook and capital allocation approach. For investors tracking Laureate Education, the larger buyback comes with the stock trading around $33.86, after a 71.9%...

CeriBell (CBLL) has just closed out FY 2025 with Q4 revenue of US$24.8 million and a basic EPS loss of US$0.36, while trailing 12 month revenue reached US$89.1 million and basic EPS over that period sat at a loss of US$1.46. The company has seen quarterly revenue move from US$18.5 million in Q4 2024 to US$24.8 million in Q4 2025, with basic EPS losses over those quarters ranging between US$0.36 and US$0.40, and trailing 12 month net income remaining in loss territory at US$53.4 million for...

Ironwood Pharmaceuticals (IRWD) just closed out FY 2025 with a mixed Q4 print, reporting revenue of US$47.7 million and a small net loss of US$2.3 million, which translated into EPS of US$0.15 for the trailing twelve months. The company has seen revenue move from US$351.4 million on a trailing basis in Q4 2024 to US$296.2 million in Q4 2025, while trailing EPS shifted from roughly flat at US$0.01 to US$0.15. This sets up a picture in which margins have recently firmed even as top line...

Supernus Pharmaceuticals FY 2025 Earnings Snapshot Supernus Pharmaceuticals (SUPN) has wrapped up FY 2025 with fourth quarter revenue of US$211.6 million, Basic EPS of a US$0.07 loss, and net income excluding extra items showing a US$4.1 million loss. The company reported an increase in revenue from US$174.2 million in Q4 2024 to US$211.6 million in Q4 2025, while Basic EPS moved from US$0.28 in Q4 2024 to a US$0.07 loss in Q4 2025. This combination highlights an expanding top line alongside...

Latest FY 2025 Results Set the Stage for Aspen Aerogels Aspen Aerogels (ASPN) has just wrapped up FY 2025 with Q4 revenue of about US$41.3 million and a basic EPS loss of US$0.88, capping a year in which trailing twelve month revenue came in at roughly US$271.1 million and EPS on the same basis was a loss of US$4.73. Over recent quarters the company has seen quarterly revenue shift from US$123.1 million in Q4 2024 to US$78.7 million in Q1 2025, US$78.0 million in Q2, US$73.0 million in Q3 and...

Euroseas (NasdaqCM:ESEA) has wrapped up FY 2025 with fourth quarter revenue of US$57.4 million and basic EPS of US$5.82, setting the tone for a year where trailing 12 month revenue reached US$227.9 million and EPS came in at US$19.73. Over recent periods, the company has seen quarterly revenue move from US$53.3 million in Q4 2024 to around US$56.3 million to US$57.4 million across 2025. Quarterly EPS shifted from US$3.51 in Q4 2024 to a range of US$4.27 to US$5.82 in 2025, with these earnings...

Graham Holdings (GHC) closed out FY 2025 with Q4 revenue of US$1.3b and basic EPS of US$25.33, alongside net income of US$109.8m, while trailing 12 month revenue came in at US$4.9b with EPS of US$67.49 and net income of US$292.3m. Over recent periods, the company has seen quarterly revenue move from US$1.21b in Q2 2025 to US$1.28b in Q3 and US$1.25b in Q4, with basic EPS ranging from US$8.43 in Q2 to US$28.19 in Q3 and US$25.33 in Q4. With a trailing net profit margin sitting at 6% compared...

Solid Power (SLDP) closed out FY 2025 with Q4 revenue of US$2.6 million and a basic EPS loss of US$0.14, alongside a trailing twelve month EPS loss of US$0.51 on revenue of US$17.9 million. This keeps the focus firmly on how quickly the business can scale against ongoing losses. Over recent quarters, the company has seen quarterly revenue move from US$4.5 million in Q4 2024 to US$6.0 million in Q1 2025, US$6.5 million in Q2 2025, US$3.7 million in Q3 2025 and US$2.6 million in Q4 2025, while...

Unisys (UIS) has just wrapped up FY 2025 with Q4 revenue of US$574.5 million and basic EPS of US$0.26, alongside full year trailing twelve month revenue of US$1.95 billion and a trailing EPS loss of US$4.79. Over recent quarters the company has seen revenue move from US$432.1 million in Q1 2025 to US$460.2 million in Q3 2025 and then to US$574.5 million in Q4. Quarterly EPS has ranged from a loss of US$4.33 in Q3 2025 to a profit of US$0.26 in Q4, leaving investors weighing how much of the...

If you are wondering whether Olaplex Holdings at US$1.65 is a bargain or a value trap, you will want a clear view of what the current share price actually reflects. The stock has recently posted returns of 1.9% over 7 days, 6.5% over 30 days, 22.2% year to date and 11.5% over 1 year. Over 3 years, the return stands at a 64.0% decline. Recent coverage of Olaplex has focused on its position in the premium hair care market and investor interest around how the brand is responding to competition...

Sun Communities (SUI) has just posted its FY 2025 results, with Q4 revenue at US$518.6 million and basic EPS of US$0.90, while trailing twelve month revenue stands at US$2.3 billion and basic EPS sits at a loss of US$0.55. Over recent quarters the company has seen quarterly revenue range from US$471.5 million to US$695.7 million and basic EPS swing between a loss of US$1.23 and a gain of US$2.10, underscoring how earnings have been far more volatile than top line performance. For investors,...

Everus Construction Group (ECG) has just wrapped up FY 2025 with fourth quarter revenue of US$1.0b and basic EPS of US$1.08, set against trailing 12 month revenue of US$3.7b and EPS of US$3.95 that sit alongside the previously reported 40.7% earnings growth over the past year. Over recent periods the company has seen quarterly revenue move from US$759.6 million in Q4 2024 to US$826.6 million in Q1 2025 and then to US$1.0b in Q4 2025, while quarterly basic EPS shifted from US$0.68 in Q4 2024...

Beam Therapeutics (BEAM) just posted its FY 2025 numbers with Q4 revenue of US$114.1 million and basic EPS of US$2.37, alongside trailing 12 month revenue of US$139.7 million and a basic EPS loss of US$0.81. Over the past six quarters, the company has seen quarterly revenue range from US$7.5 million to US$114.1 million, while basic EPS has swung from a loss of US$1.24 per share to a gain of US$2.37 per share, reflecting a wide earnings range around its R&D heavy model. For investors, the...

Icahn Enterprises (IEP) just closed out FY 2025 with Q4 revenue of US$2.7b and basic EPS of US$0.00, while trailing twelve month figures show revenue of US$9.7b and a basic EPS loss of US$0.52. Over recent quarters, the company has seen revenue move from US$2.6b in Q4 2024 to US$1.9b in Q1 2025 and then back to US$2.7b in Q4 2025, alongside basic EPS swinging from a loss of US$0.79 in Q1 2025 to a small profit in Q4. This leaves investors weighing how much of this EPS recovery reflects...

APi Group (APG) just wrapped up FY 2025 with Q4 revenue of about US$2.1 billion and a basic EPS loss of US$1.19, capping a twelve month stretch where trailing revenue reached roughly US$7.9 billion and trailing EPS stood at a loss of US$0.69. Over recent quarters, the company has seen revenue move from US$1.9 billion in Q4 2024 to US$2.1 billion in Q4 2025, while quarterly EPS shifted from a loss of US$0.07 to a loss of US$1.19. This sets the stage for investors to focus squarely on how...

Sila Realty Trust (SILA) just reported Q4 FY 2025 results with total revenue of US$50.7 million and basic EPS of US$0.09, alongside funds from operations of US$29.8 million, which is a key metric for REIT investors. The company has seen revenue move from US$46.5 million in Q4 FY 2024 to US$50.7 million in Q4 FY 2025, while trailing 12 month basic EPS stands at US$0.60 and trailing net income is US$33.1 million. Investors will be weighing these figures against expectations for future growth...

Q2 2026 earnings snapshot Manchester United (MANU) has just posted Q2 2026 results with revenue of £190.3 million and basic EPS of £0.024, alongside net income of £4.2 million, putting a profit quarter next to a still loss-making trailing twelve month profile. The club has seen quarterly revenue move between £143.1 million and £198.7 million over the past six reported periods, while basic EPS has ranged from a loss of £0.163 to a profit of £0.024, giving investors a mixed read on headline...

Lineage (LINE) has wrapped up FY 2025 with fourth quarter revenue of US$1.3 billion, basic EPS of US$0.02 and net income excluding extra items of US$4 million, alongside adjusted funds from operations of US$214 million.

If you are wondering whether Chemours is offering good value at its current price, or if the recent moves are signaling something else about the stock, this article focuses squarely on what the numbers say about value. Chemours' share price closed at US$18.02, with returns of 14.1% over the last 30 days, 47.1% year to date and 16.9% over the past year, while the 7-day return of a 14.8% decline and longer term 3-year and 5-year returns of 42.4% and a 16.4% decline show a mixed picture for...

GoDaddy (GDDY) just posted its FY 2025 numbers with Q4 revenue of US$1.27 billion and basic EPS of US$1.82, while trailing 12 month revenue came in at US$5.0 billion and EPS at US$6.34. Over the past six quarters, revenue has moved from US$1.15 billion in Q3 2024 to US$1.27 billion in Q4 2025, with quarterly EPS ranging from US$1.36 in Q3 2024 to US$1.82 in the latest quarter. Investors may now focus on how these top line and EPS trends line up with expected earnings growth. With net margins...

Evolent Health FY 2025 earnings snapshot Evolent Health (EVH) closed FY 2025 with fourth quarter revenue of US$468.7 million and a basic EPS loss of US$3.84, as the company continued to report negative net income. Over recent periods, revenue has ranged from US$444.3 million to US$483.6 million per quarter, while quarterly basic EPS has stayed in loss-making territory between US$0.24 and US$3.84. This gives investors a clear view of the trade off between top line scale and ongoing earnings...